1. Home
  2. GBNH

GBNH

Greenbrook TMS Inc.

Logo Greenbrook TMS Inc.

Health Care

Misc Health and Biotechnology Services

Nasdaq

as 03-07-2024 9:37am EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.

Founded: 2011 Country:
Canada
Canada
Employees: N/A City: N/A
Market Cap: 5.2M IPO Year: N/A
Target Price: $1.88 AVG Volume (30 days): 2.6M
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.07 EPS Growth: N/A
52 Week Low/High: $0.10 - $1.82 Next Earning Date: 04-15-2024
Revenue: $77,367,044 Revenue Growth: 24.63%
Revenue Growth (this year): 10.19% Revenue Growth (next year): 19.76%

Share on Social Networks: